|
1
|
Ogle GD, Wang F, Haynes A, Gregory GA,
King TW, Deng K, Dabelea D, James S, Jenkins AJ, Li X, et al:
Global type 1 diabetes prevalence, incidence, and mortality
estimates 2025: Results from the International Diabetes Federation
Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res
Clin Pract. 225(112277)2025.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dedrick S, Sundaresh B, Huang Q, Brady C,
Yoo T, Cronin C, Rudnicki C, Flood M, Momeni B, Ludvigsson J and
Altindis E: The role of gut microbiota and environmental factors in
type 1 diabetes pathogenesis. Front Endocrinol (Lausanne).
11(78)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Penders J, Thijs C, Vink C, Stelma FF,
Snijders B, Kummeling I, Van den Brandt PA and Stobberingh EE:
Factors influencing the composition of the intestinal microbiota in
early infancy. Pediatrics. 118:511–521. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gradisteanu Pircalabioru G, Corcionivoschi
N, Gundogdu O, Chifiriuc MC, Marutescu LG, Ispas B and Savu O:
Dysbiosis in the development of type I diabetes and associated
complications: From mechanisms to targeted gut microbes
manipulation therapies. Int J Mol Sci. 22(2763)2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rampanelli E and Nieuwdorp M: Gut
microbiome in type 1 diabetes: The immunological perspective.
Expert Rev Clin Immunol. 19:93–109. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Abuqwider J, Corrado A, Scidà G, Lupoli R,
Costabile G, Mauriello G and Bozzetto L: Gut microbiome and blood
glucose control in type 1 diabetes: A systematic review. Front
Endocrinol (Lausanne). 14(1265696)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wen L, Ley RE, Volchkov PY, Stranges PB,
Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA,
et al: Innate immunity and intestinal microbiota in the development
of type 1 diabetes. Nature. 455:1109–1113. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Markle JG, Frank DN, Mortin-Toth S,
Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD,
Macpherson AJ and Danska JS: Sex differences in the gut microbiome
drive hormone-dependent regulation of autoimmunity. Science.
339:1084–1088. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hansen CH, Krych L, Nielsen DS, Vogensen
FK, Hansen LH, Sørensen SJ, Buschard K and Hansen AK: Early life
treatment with vancomycin propagates Akkermansia muciniphila and
reduces diabetes incidence in the NOD mouse. Diabetologia.
55:2285–2294. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Maffeis C, Martina A, Corradi M, Quarella
S, Nori N, Torriani S, Plebani M, Contreas G and Felis GE:
Association between intestinal permeability and faecal microbiota
composition in Italian children with beta cell autoimmunity at risk
for type 1 diabetes. Diabetes Metab. Res Rev. 32:700–709.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kostic AD, Gevers D, Siljander H, Vatanen
T, Hyötyläinen T, Hämäläinen AM, Peet A, Tillmann V, Pöhö P,
Mattila I, et al: The dynamics of the human infant gut microbiome
in development and in progression toward type 1 diabetes. Cell Host
Microbe. 17:260–273. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ziegler AG, Hoffmann GF, Hasford J,
Larsson HE, Danne T, Berner R, Penno M, Koralova A, Dunne J and
Bonifacio E: Screening for asymptomatic β-cell autoimmunity in
young children. Lancet Child Adolesc Health. 3:288–290.
2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Vaarala O: Gut microbiota and type 1
diabetes. Rev Diabet Stud. 9:251–259. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Vatanen T, Franzosa EA, Schwager R,
Tripathi S, Arthur TD, Vehik K, Lernmark Å, Hagopian WA, Rewers MJ,
She JX, et al: The human gut microbiome in early-onset type 1
diabetes from the TEDDY study. Nature. 562:589–594. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Bäckhed F, Ley RE, Sonnenburg JL, Peterson
DA and Gordon JI: Host-bacterial mutualism in the human intestine.
Science. 307:1915–1920. 2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Murri M, Leiva I, Gomez-Zumaquero JM,
Tinahones FJ, Cardona F, Soriguer F and Queipo-Ortuño MI: Gut
microbiota in children with type 1 diabetes differs from that in
healthy children: A case-control study. BMC Med.
11(46)2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Arts RJW, Joosten LAB and Netea MG: The
potential role of trained immunity in autoimmune and
autoinflammatory disorders. Front Immunol. 9(298)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Marchesi JR and Ravel J: The vocabulary of
microbiome research: A proposal. Microbiome. 3(31)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jung TH, Han KS, Park JH and Hwang HJ:
Butyrate modulates mucin secretion and bacterial adherence in LoVo
cells via MAPK signaling. PLoS One. 17(e0269872)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vatanen T, de Beaufort C, Marcovecchio ML,
Overbergh L, Brunak S, Peakman M, Mathieu C and Knip M: INNODIA
consortium. Gut microbiome shifts in people with type 1 diabetes
are associated with glycaemic control: An INNODIA study.
Diabetologia. 67:1930–1942. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Flint HJ, Scott KP, Duncan SH, Louis P and
Forano E: Microbial degradation of complex carbohydrates in the
gut. Gut Microbes. 3:289–306. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hague A, Butt AJ and Paraskeva C: The role
of butyrate in human colonic epithelial cells: An energy source or
inducer of differentiation and apoptosis? Proc Nutr Soc.
55:937–943. 1996.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lopetuso LR, Scaldaferri F, Petito V and
Gasbarrini A: Commensal Clostridia: Leading players in the
maintenance of gut homeostasis. Gut Pathog. 5(23)2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Leiva-Gea I, Sánchez-Alcoholado L,
Martín-Tejedor B, Castellano-Castillo D, Moreno-Indias I,
Urda-Cardona A, Tinahones FJ, Fernández-García JC and Queipo-Ortuño
MI: Gut microbiota differs in composition and functionality between
children with type 1 Diabetes and MODY2 and healthy control
subjects: A case-control study. Diabetes Care. 41:2385–2395.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Brown CT, Davis-Richardson A, Giongo A,
Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip
M, et al: Gut microbiome metagenomics analysis suggests a
functional model for the development of autoimmunity for type 1
diabetes. PLoS One. 6(e25792)2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Valladares R, Sankar D, Li N, Williams E,
Lai KK, Abdelgeliel AS, Gonzalez CF, Wasserfall CH, Larkin J,
Schatz D, et al: Lactobacillus johnsonii N6.2 mitigates the
development of type 1 diabetes in BB-DP rats. PLoS One.
5(e10507)2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Human Microbiome Project Consortium.
Structure, function and diversity of the healthy human microbiome.
Nature. 486:207–214. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hypponen E: Vitamin D and increasing
incidence of type 1 diabetes-evidence for an association? Diabetes
Obes Metab. 12:737–743. 2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chia LW, Mank M, Blijenberg B, Aalvink S,
Bongers RS, Stahl B, Knol J and Belzer C: Bacteroides
thetaiotaomicron fosters the growth of butyrate-producing
Anaerostipes caccae in the presence of lactose and total human milk
carbohydrates. Microorganisms. 8(1513)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zipitis CS and Akobeng AK: Vitamin D
supplementation in early childhood and risk of type 1 diabetes: A
systematic review and meta-analysis. Arch Dis Child. 93:512–517.
2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Karvonen M, Viik-Kajander M, Moltchanova
E, Libman I, LaPorte R and Tuomilehto J: Incidence of childhood
type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project
Group. Diabetes Care. 23:1516–1526. 2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pozzilli P, Manfrini S, Crinò A, Picardi
A, Leomanni C, Cherubini V, Valente L, Khazrai M and Visalli N:
IMDIAB group. Low levels of 25-hydroxyvitamin D3 and
1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1
diabetes. Horm Metab Res. 37:680–683. 2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Borkar VV, Devidayal Verma S and Bhalla
AK: Low levels of vitamin D in North Indian children with newly
diagnosed type 1 diabetes. Pediatr Diabetes. 11:345–50.
2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hagopian WA, Erlich H, Lernmark Å, Rewers
M, Ziegler AG, Simell O, Akolkar B, Vogt R Jr, Blair A, Ilonen J,
et al: The environmental determinants of diabetes in the young
(TEDDY): Genetic criteria and international diabetes risk screening
of 421,000 infants. Pediatr Diabetes. 12:733–743. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lönnrot M, Lynch KF, Elding Larsson H,
Lernmark Å, Rewers MJ, Törn C, Burkhardt BR, Briese T, Hagopian WA,
She JX, et al: TEDDY study group: Respiratory infections are
temporally associated with initiation of type 1 diabetes
autoimmunity: The TEDDY study. Diabetologia. 60:1931–1940.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rewers M and Ludvigsson J: Environmental
risk factors for type 1 diabetes. Lancet. 387:2340–2348.
2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vlad A, Serban V, Green A, Möller S, Vlad
M, Timar B and Sima A: ONROCAD Study Group. Time trends, regional
variability and seasonality regarding the incidence of type 1
diabetes mellitus in Romanian children aged 0-14 years, between
1996 and 2015. J Clin Res Pediatr Endocrinol. 10:92–99.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ionescu-Tîrgoviște C, Guja C, Călin A and
Moţa M: An increasing trend in the incidence of type 1 diabetes
mellitus in children aged 0-14 years in Romania-ten years
(1988-1997) EURODIAB study experience. J Pediatr Endocrinol Metab.
17:983–991. 2004.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gyürüs EK, Patterson C and Soltész G:
Hungarian Childhood Diabetes Epidemiology Group. Twenty-one years
of prospective incidence of childhood type 1 diabetes in
Hungary-the rising trend continues (or peaks and highlands?).
Pediatr Diabetes. 13:21–25. 2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jarosz-Chobot P, Polańska J, Szadkowska A,
Kretowski A, Bandurska-Stankiewicz E, Ciechanowska M, Deja G,
Mysliwiec M, Peczynska J, Rutkowska J, et al: Rapid increase in the
incidence of type 1 diabetes in Polish children from 1989 to. 2004,
and predictions for 2010 to 2025. Diabetologia. 54:508–515.
2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Usher-Smith JA, Thompson M, Ercole A and
Walter FM: Variation between countries in the frequency of diabetic
ketoacidosis at first presentation of type 1 diabetes in children:
A systematic review. Diabetologia. 55:2878–2894. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Triolo TM, Armstrong TK, McFann K, Yu L,
Rewers MJ, Klingensmith GJ, Eisenbarth GS and Barker JM: Additional
autoimmune disease found in 33% of patients at type 1 diabetes
onset. Diabetes Care. 34:1211–1213. 2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Akhtadze E, Cilio CM, Hansen I, Gerdes AM,
Mortensen HB, Pociot F and Nerup J: Distribution of autoimmune
diseases in Danish children and adolescents with type 1 diabetes
mellitus. Horm Res. 65:193–198. 2006.
|
|
44
|
ElSayed NA, Aleppo G, Aroda VR, Bannuru
RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D,
Johnson EL, et al: 2. Classification and diagnosis of diabetes:
Standards of Medical Care in Diabetes-2023. Diabetes Care. 46
(Suppl 1):S19–S40. 2023.PubMed/NCBI View Article : Google Scholar
|
|
45
|
de Groot PF, Belzer C, Levels JH, Aalvink
S, Boot F, Holleman F, Van Raalte DH, Scheithauer TP, Simsek S,
Schaap FG, et al: Distinct fecal and oral microbiota composition in
human type 1 diabetes, an observational study. PLoS One.
12(e0188475)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Thomson G, Valdes AM, Noble JA, Kockum I,
Grote MN, Najman J, Erlich HA, Cucca F, Pugliese A, Steenkiste A,
et al: Relative predispositional effects of HLA class II DRB1-DQB1
haplotypes genotypes on type 1 diabetes: a meta-analysis. Tissue
Antigens. 70:110–127. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Emmanuel M and Bokor BR: Tanner Stages.
2022 Dec 11. In StatPearls. StatPearls Publishing, Treasure Island,
FL, 2025. https://www.ncbi.nlm.nih.gov/books/NBK470280/.
|
|
48
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and β-cell function from fasting plasma glucose
and insulin concentrations in man. Diabetologia. 28:412–419.
1985.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Trandafir M, Pircalabioru GG and Savu O:
Microbiota analysis in individuals with type two diabetes mellitus
and end-stage renal disease: A pilot study. Exp Ther Med.
27(211)2024.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Srinivasan R, Karaoz U, Volegova M,
MacKichan J, Kato-Maeda M, Miller S, Nadarajan R, Brodie EL and
Lynch SV: Use of 16S rRNA gene for identification of a broad range
of clinically relevant bacterial pathogens. PLoS One.
10(e0117617)2015.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Giongo A, Gano KA, Crabb DB, Mukherjee N,
Novelo LL, Casella G, Drew JC, Ilonen J, Knip M, Hyöty H, et al:
Toward defining the autoimmune microbiome for type 1 diabetes. ISME
J. 5:82–91. 2011.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Gradisteanu Pircalabioru G, Chifiriuc MC,
Picu A, Petcu LM, Trandafir M and Savu O: Snapshot into the
type-2-diabetes-associated microbiome of a romanian cohort. Int J
Mol Sci. 23(15023)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Gradisteanu Pircalabioru G, Ilie I, Oprea
L, Picu A, Petcu LM, Burlibasa L, Chifiriuc MC and Musat M:
Microbiome, mycobiome and related metabolites alterations in
patients with metabolic syndrome-a pilot study. Metabolites.
12(218)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Hull CM, Peakman M and Tree TIM:
Regulatory T cell dysfunction in type 1 diabetes: what's broken and
how can we fix it? Diabetologia. 60:1839–1850. 2017.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Alnek K, Tagoma A, Metsküla K, Talja I,
Janson H, Mandel M, Vorobjova T, Oras A, Sepp H, Pruul K, et al:
Comparison of immunological and immunogenetic markers in
recent-onset type 1 diabetes among children and adults. Sci Rep.
15(15491)2025.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Mazzoni MB, Roversi M, Maltoni G, Biasucci
G, Berardi A, Tonielli E, Cicognani A and Salardi S: Gualandi.
Recurrent infections in children and adolescents with type 1
diabetes mellitus: A case-control study. BMC Infect Dis.
18(599)2018.
|
|
58
|
Hygum K, Starup-Linde J, Harsløf T,
Vestergaard P and Langdahl BL: Mechanisms in endocrinology:
Diabetes mellitus, a state of low bone turnover-a systematic review
and meta-analysis. Eur J Endocrinol. 176:R137–R157. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Knudsen JK, Leutscher P and Sørensen S:
Gut microbiota in bone health and diabetes. Curr Osteoporos Rep.
19:462–479. 2021.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Janner M and Saner C: Impact of type 1
diabetes mellitus on bone health in children. Horm Res Paediatr.
95:205–214. 2022.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Round JL and Mazmanian SK: Inducible
Foxp3+ regulatory T-cell development by a commensal bacterium of
the intestinal microbiota. Proc Natl Acad Sci USA. 107:12204–12209.
2010.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Mazmanian SK, Round JL and Kasper DL: A
microbial symbiosis factor prevents intestnal inflammatory disease.
Nature. 453:620–625. 2008.PubMed/NCBI View Article : Google Scholar
|
|
63
|
den Besten G, van Eunen K, Groen AK,
Venema K, Reijngoud DJ and Bakker BM: The role of short-chain fatty
acids in the interplay between diet, gut microbiota and host energy
metabolism. J Lipid Res. 54:2325–2340. 2013.PubMed/NCBI View Article : Google Scholar
|
|
64
|
de Groot PF, Belzer C, Aydin Ö, Levin E,
Levels JH, Aalvink S, Boot F, Holman R, Reitsma PH, Gerdes VE and
Nieuwdorp M: Distinct fecal and oral microbiota composition in
human type 1 diabetes, an observational study. PLoS ONE.
12(e0188475)2017.PubMed/NCBI View Article : Google Scholar
|
